RAM
ETON icon

Roumell Asset Management’s Eton Pharmaceutcials ETON Stock Holding History

Roumell Asset Management’s Portfolio ETON Stock Details ETON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-449,438
Closed -$1.26M – 23
2022
Q4 		$1.26M Hold
449,438
– – 3.12% 11
2022
Q3 		$944K Hold
449,438
– – 2.04% 16
2022
Q2 		$1.18M Hold
449,438
– – 2.29% 14
2022
Q1 		$1.96M Hold
449,438
– – 3.17% 10
2021
Q4 		$1.93M Buy
+449,438
New +$2.15M 2.57% 13

Other funds holding ETON

OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WIM
Westside Investment Management Santa Monica, California $653M AUM 28.36% 1-Year Est. Return
AI
Acuitas Investments Seattle, Washington $1.41M AUM 48.57% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
SWP
Stratos Wealth Partners Beachwood, Ohio $8.8B AUM 21.82% 1-Year Est. Return

Roumell Asset Management's ETON Position: Q1 2023 in Review

Roumell Asset Management sold out of Eton Pharmaceutcials (ETON) in Q1 2023, closing a stake of 449,438 shares — an estimated $1.26M sold.

Roumell Asset Management first reported a position in ETON in Q4 2021 and held it in 5 quarters. The position peaked at $1.96M in Q1 2022. 35 funds tracked by Wall St. Rank hold ETON as of Q1 2023.

  • Roumell Asset Management reported no remaining Eton Pharmaceutcials position as of Q1 2023 after selling out during the quarter.
  • Roumell Asset Management sold 449,438 Eton Pharmaceutcials shares in Q1 2023, an estimated $1.26M.
  • Roumell Asset Management first reported a position in Eton Pharmaceutcials in Q4 2021 and held it in 5 quarters.
  • Roumell Asset Management's Eton Pharmaceutcials position peaked at $1.96M in Q1 2022.
  • 35 funds tracked by Wall St. Rank held Eton Pharmaceutcials as of Q1 2023.

Based on Roumell Asset Management's 13F filing for Q1 2023, filed 12 May 2023.